Perspective Therapeutics, Inc.

S$5.312
SGD
Last updated on --.
24h volume1.44M
24h highest5.3830 SGD
24h lowest5.0331 SGD
24h Price movement+4.52%

CATX recent prices

24 Hours
+4.52%+S$0.22988
30 days
-2.58%-S$0.14048
60 days
-2.21%-S$0.11494
90 days
-17.79%-S$1.150

Key data

Previous close5.0829 SGD
Market cap549.09M SGD
Volume1.44M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.2388 SGD
Net income (FY)-142.58M SGD
Revenue (FY)789.25K SGD
Last report date11 May 2026

About Perspective Therapeutics, Inc.

PHARMACEUTICAL PREPARATIONS
HeadquartersSEATTLE
Employees (FY)166.00
Revenue per employee (FY)4.75K SGD
Net income per employee (FY)-858.94K SGD
Listed onXASE
Official website

CATX conversion tables

CATXCATX
SGDSGD
0.5 CATX2.656 SGD
1 CATX5.312 SGD
5 CATX26.56 SGD
10 CATX53.12 SGD
SGDSGD
CATXCATX
0.5 SGD0.094113 CATX
1 SGD0.18823 CATX
5 SGD0.94113 CATX
10 SGD1.882 CATX

FAQ

CATX is trading at S$5.312, +4.52% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CATX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CATX is currently trading at S$5.312, +4.52% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CATX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CATX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CATX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CATX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Perspective Therapeutics, Inc.'s market cap is currently 549.09M SGD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.44M
24h highest5.3830 SGD
24h lowest5.0331 SGD
24h Price movement+4.52%
CATXCATX
SGDSGD
Start trade with CATX Perpetual